Literature DB >> 26405153

Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with normal karyotype and isolated Nucleophosmin-1 (NPM1) mutation: outcome strongly correlates with disease status.

Ali Bazarbachi1, Myriam Labopin2, Mohamed A Kharfan-Dabaja3, Rainer Schwerdtfeger4, Liisa Volin5, Jean Henri Bourhis6, Gérard Socié7, Etienne Daguindau8, Tobias Gedde-Dahl9, Alessandro Rambaldi10, Michal Karas11, Günter Schlimok12, Didier Blaise13, Patrice Chevallier14, Florent Malard2, Christoph Schmid15, Jordi Esteve16, Arnon Nagler17, Mohamad Mohty2.   

Abstract

Entities:  

Keywords:  AML; NPM1; complete remission; transplantation

Mesh：

Substances：

Year:  2015        PMID： 26405153      PMCID： PMC4697906          DOI： 10.3324/haematol.2015.135681

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  11 in total

Review 1.  Acute myeloid leukemia.

Authors:  B Löwenberg; J R Downing; A Burnett
Journal:  N Engl J Med       Date:  1999-09-30       Impact factor: 91.245

Review 2.  Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?

Authors:  Brunangelo Falini; Maria Paola Martelli; Niccolò Bolli; Paolo Sportoletti; Arcangelo Liso; Enrico Tiacci; Torsten Haferlach
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

3.  Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

Authors:  Jay P Patel; Mithat Gönen; Maria E Figueroa; Hugo Fernandez; Zhuoxin Sun; Janis Racevskis; Pieter Van Vlierberghe; Igor Dolgalev; Sabrena Thomas; Olga Aminova; Kety Huberman; Janice Cheng; Agnes Viale; Nicholas D Socci; Adriana Heguy; Athena Cherry; Gail Vance; Rodney R Higgins; Rhett P Ketterling; Robert E Gallagher; Mark Litzow; Marcel R M van den Brink; Hillard M Lazarus; Jacob M Rowe; Selina Luger; Adolfo Ferrando; Elisabeth Paietta; Martin S Tallman; Ari Melnick; Omar Abdel-Wahab; Ross L Levine
Journal:  N Engl J Med       Date:  2012-03-14       Impact factor: 91.245

4.  Allogeneic stem-cell transplantation in patients with NPM1-mutated acute myeloid leukemia: results from a prospective donor versus no-donor analysis of patients after upfront HLA typing within the SAL-AML 2003 trial.

Authors:  Christoph Röllig; Martin Bornhäuser; Michael Kramer; Christian Thiede; Anthony D Ho; Alwin Krämer; Kerstin Schäfer-Eckart; Hannes Wandt; Mathias Hänel; Hermann Einsele; Walter E Aulitzky; Norbert Schmitz; Wolfgang E Berdel; Matthias Stelljes; Carsten Müller-Tidow; Utz Krug; Uwe Platzbecker; Martin Wermke; Claudia D Baldus; Stefan W Krause; Friedrich Stölzel; Malte von Bonin; Markus Schaich; Hubert Serve; Johannes Schetelig; Gerhard Ehninger
Journal:  J Clin Oncol       Date:  2014-12-29       Impact factor: 44.544

5.  Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report.

Authors:  Fabiana Ostronoff; Megan Othus; Michelle Lazenby; Elihu Estey; Frederick R Appelbaum; Anna Evans; John Godwin; Amanda Gilkes; Kenneth J Kopecky; Alan Burnett; Alan F List; Min Fang; Vivian G Oehler; Stephen H Petersdorf; Era L Pogosova-Agadjanyan; Jerald P Radich; Cheryl L Willman; Soheil Meshinchi; Derek L Stirewalt
Journal:  J Clin Oncol       Date:  2015-02-23       Impact factor: 44.544

6.  Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance.

Authors:  Roel G W Verhaak; Chantal S Goudswaard; Wim van Putten; Maarten A Bijl; Mathijs A Sanders; Wendy Hugens; André G Uitterlinden; Claudia A J Erpelinck; Ruud Delwel; Bob Löwenberg; Peter J M Valk
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

7.  Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype.

Authors:  Susanne Schnittger; Claudia Schoch; Wolfgang Kern; Cristina Mecucci; Claudia Tschulik; Massimo F Martelli; Torsten Haferlach; Wolfgang Hiddemann; Brunangelo Falini
Journal:  Blood       Date:  2005-08-02       Impact factor: 22.113

8.  Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.

Authors:  Richard F Schlenk; Konstanze Döhner; Jürgen Krauter; Stefan Fröhling; Andrea Corbacioglu; Lars Bullinger; Marianne Habdank; Daniela Späth; Michael Morgan; Axel Benner; Brigitte Schlegelberger; Gerhard Heil; Arnold Ganser; Hartmut Döhner
Journal:  N Engl J Med       Date:  2008-05-01       Impact factor: 91.245

Review 9.  Acute myeloid leukaemia in adults.

Authors:  Felicetto Ferrara; Charles A Schiffer
Journal:  Lancet       Date:  2013-02-09       Impact factor: 79.321

10.  Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.

Authors:  Stefan Fröhling; Richard F Schlenk; Jochen Breitruck; Axel Benner; Sylvia Kreitmeier; Karen Tobis; Hartmut Döhner; Konstanze Döhner
Journal:  Blood       Date:  2002-08-08       Impact factor: 22.113
View more
  3 in total

1.  [Prognostic significance of early assessment of minimal residual disease in acute myeloid leukemia with mutated NPM1 patients].

Authors:  T Zhao; H H Zhu; J Wang; J S Jia; S M Yang; H Jiang; J Lu; H Chen; L P Xu; X H Zhang; B Jiang; G R Ruan; D B Wang; X J Huang; Q Jiang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-01-14

2.  Molecular Detection of Minimal Residual Disease before Allogeneic Stem Cell Transplantation Predicts a High Incidence of Early Relapse in Adult Patients with NPM1 Positive Acute Myeloid Leukemia.

Authors:  Federico Lussana; Chiara Caprioli; Paola Stefanoni; Chiara Pavoni; Orietta Spinelli; Ksenija Buklijas; Anna Michelato; GianMaria Borleri; Alessandra Algarotti; Caterina Micò; Anna Grassi; Tamara Intermesoli; Alessandro Rambaldi
Journal:  Cancers (Basel)       Date:  2019-09-28       Impact factor: 6.639

3.  Measurable residual disease, FLT3-ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1-mutated acute myeloid leukemia.

Authors:  Rama Al Hamed; Myriam Labopin; Etienne Daguindau; Riitta Niittyvuopio; Anne Huynh; Gerard Socié; Micha Srour; Jean Henri Bourhis; Nicolaus Kröger; Eleni Tholouli; Goda Choi; Xavier Poiré; Hans Martin; Marie-Thérèse Rubio; Pavel Jindra; Didier Blaise; Dietrich Beelen; Hélène Labussière-Wallet; Arnon Nagler; Ali Bazarbachi; Mohamad Mohty
Journal:  Cancer Med       Date:  2022-01-20       Impact factor: 4.452
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.